{
  "id": 9082194,
  "title": "Nigerian Firm, Ash Biomedical, Produces Seven Medications for HIV, Malaria, Hepatitis, Pregnancy",
  "url": "https://urgent.news/2026/09/22/nigerian-firm-ash-biomedical-produces-seven-medications-for-hiv",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T04:32:20.000Z",
  "source": {
    "name": "This Day",
    "slug": "this-day",
    "url": "https://www.thisdaylive.com/2026/09/22/nigerian-firm-ash-biomedical-produces-seven-medications-for-hiv-malaria-hepatitis-pregnancy/"
  },
  "original_language": "en",
  "account": "Nigerian biomedical company Ash Biomedical Diagnostics Ltd. has unveiled seven new diagnostic medicines to combat HIV, malaria, hepatitis, and pregnancy. The company's Managing Director, Adetoyese Shodeinde, revealed that the products span four critical healthcare testing areas and comprise 12 Stock Keeping Units (SKUs). These include ABD HIVChek, MalChek, MalChek Plus, HepaQuik, HepaQuik Duo, PregSure, and FlaviQuik. Shodeinde emphasized that this milestone reflects years of investment in quality, regulatory compliance, and product development. The newest additions, FlaviQuik and HepaQuik Duo, are designed for rapid Hepatitis C testing and dual screening for Hepatitis B and C, respectively. These additions support healthcare providers in identifying individuals who may require further medical evaluation during a single patient encounter. Shodeinde highlighted that the milestone signifies progress in strengthening confidence in locally developed healthcare solutions and expanding access to rapid diagnostics. He added that the company's vision extends beyond producing diagnostic kits, aiming to build confidence in Nigerian healthcare manufacturing through quality, reliability, and national regulatory approval.",
  "summary": "Adedayo Akinwale in Abuja A Nigerian firm, Ash Biomedical Diagnostics Ltd., has announced the production of seven of its own-brand diagnostic medicine to manage and treat HIV, malaria, hepatitis, and",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}